Crossmark

CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook

Crossref DOI link: https://doi.org/10.1007/s12672-025-03383-5

Published Online: 2025-08-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Noormohamadi, Hanieh https://orcid.org/0000-0002-9755-2850
Soleimani Samarkhazan, Hamed https://orcid.org/0000-0003-1045-7613
kargar, Maryam https://orcid.org/0000-0001-7922-7942
Maroufi, Faezeh https://orcid.org/0000-0003-1368-8636
Servatian, Nazli https://orcid.org/0000-0002-7120-9173
Davami, Fatemeh https://orcid.org/0000-0002-7693-2926
License Information

Text and Data Mining valid from 2025-08-11

Version of Record valid from 2025-08-11
More Information

Article History

Received: 21 June 2025

Accepted: 4 August 2025

First Online: 11 August 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.